This inventor holds 1 USPTO granted patent. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Scott E Davis: Innovator in Antisense Modulation
Introduction
Scott E Davis is a notable inventor based in Leucadia, California. He has made significant contributions to the field of biotechnology, particularly in the modulation of CD40 ligand expression. His innovative work has implications for treating various diseases associated with this expression.
Latest Patents
Scott E Davis holds a patent for "Antisense modulation of CD40 ligand expression." This patent involves antisense compounds, compositions, and methods designed to modulate the expression of CD40 ligand. The compositions include antisense oligonucleotides that target nucleic acids encoding CD40 ligand. The methods outlined in the patent provide approaches for using these compounds to modulate CD40 ligand expression and treat diseases linked to its expression.
Career Highlights
Scott E Davis is associated with Isis Pharmaceuticals, Inc., a company known for its focus on RNA-targeted therapeutics. His work at the company has allowed him to explore innovative solutions in the biotechnology sector. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.
Collaborations
Some of his notable coworkers include Brenda F Baker and C Frank Bennett. Their collaboration has likely contributed to the advancements in research and development within the company.
Conclusion
Scott E Davis exemplifies the spirit of innovation in biotechnology through his work on antisense modulation. His contributions have the potential to impact the treatment of diseases significantly.